Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Sendaydiego

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Racial and Ethnic Health Disparities|August 3, 2021
Prevalence and Susceptibility to Hepatitis B virus and the Need for Community Health Education in Milwaukee's Hmong CommunityMatthew Kosasih, Xavier Sendaydiego, Kate Bednarke, et al.
Antioxidants (Basel, Switzerland)|August 26, 2023
Carvedilol Phenocopies PGC-1α Overexpression to Alleviate Oxidative Stress, Mitochondrial Dysfunction and Prevent Doxorubicin-Induced Toxicity in Human iPSC-Derived CardiomyocytesNnamdi Uche, Qiang Dai, Shuping Lai, et al.
Rheumatology (Oxford, England)|February 12, 2025
Comparative safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs for cardiovascular outcomes in rheumatoid arthritisXavier Sendaydiego, Laura S Gold, Maureen Dubreuil, et al.
JAMA Network Open|November 20, 2024
Use of Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs and Cancer RiskXavier Sendaydiego, Laura S Gold, Maureen Dubreuil, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Racial and Ethnic Health Disparities|August 3, 2021
Prevalence and Susceptibility to Hepatitis B virus and the Need for Community Health Education in Milwaukee's Hmong CommunityMatthew Kosasih, Xavier Sendaydiego, Kate Bednarke, et al.
Antioxidants (Basel, Switzerland)|August 26, 2023
Carvedilol Phenocopies PGC-1α Overexpression to Alleviate Oxidative Stress, Mitochondrial Dysfunction and Prevent Doxorubicin-Induced Toxicity in Human iPSC-Derived CardiomyocytesNnamdi Uche, Qiang Dai, Shuping Lai, et al.
Rheumatology (Oxford, England)|February 12, 2025
Comparative safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs for cardiovascular outcomes in rheumatoid arthritisXavier Sendaydiego, Laura S Gold, Maureen Dubreuil, et al.
JAMA Network Open|November 20, 2024
Use of Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs and Cancer RiskXavier Sendaydiego, Laura S Gold, Maureen Dubreuil, et al.
Pageof 1